A PHASE 1, OPEN-LABEL EVALUATION OF THE PHARMACOKINETICS AND SAFETY OF A SINGLE DOSE OF APRAGLUTIDE IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL FUNCTION
Gerard Greig 1
Danni Cong 2
Niamh Hurley 1
Eric Michel 1
Nader N. Youssef 1
1 VectivBio, Basel, Switzerland
2 ICON PRA Health Sciences, Dublin, Ireland
Session
Small intestinal (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]